South Dakota 2024 Regular Session

South Dakota House Bill HB1168

Introduced
1/25/24  

Caption

Require the dispensing of drugs prescribed for an off-label use during a public health emergency.

Impact

The bill's implementation could significantly influence state regulations governing pharmacy practices and the authority of pharmacists in South Dakota. By providing a legal framework for off-label dispensing during emergencies, the bill would effectively alter existing laws to prioritize swift and adaptive healthcare responses. This change may lead to increased collaboration between healthcare providers in managing public health crises by allowing them to utilize a broader range of medications, which could be crucial in scenarios where standard treatments are ineffective or unavailable.

Summary

House Bill 1168 is a legislative proposal aimed at facilitating the dispensing of drugs by pharmacists when prescribed for off-label use during declared public health emergencies. The bill mandates that during such emergencies, pharmacists are required to dispense prescription drug orders specifically written for off-label uses, thereby enhancing access to potentially necessary treatments that may not have been explicitly approved for those indications by the FDA. This change aims to address the urgent healthcare needs that may arise in crisis situations, allowing for a more flexible response to public health concerns.

Contention

While proponents of HB 1168 argue that allowing off-label drug use during emergency situations can save lives and improve health outcomes, there may be concerns regarding the safety and efficacy of off-label prescriptions. Opponents of the bill could argue that it may encourage dispensing practices that lack rigorous oversight or adequate patient education, potentially endangering public safety. Additionally, there are fears that the bill could lead to an increase in misuse of medications if not properly regulated, complicating the already critical responsibility of pharmacists and healthcare professionals in drug dispensation.

Companion Bills

No companion bills found.

Previously Filed As

SD HB1135

Provide for transparency in the pricing of prescription drugs.

SD HB1102

Clarify and modify requirements related to the medical cannabis program.

SD SB27

Place certain substances on the controlled substances schedule and to declare an emergency.

SD HB1172

Require a practitioner's medical assessment of a patient to occur in certain facilities for purposes of medical cannabis use.

SD SB101

Provide the Department of Health with oversight authority for the provision of emergency medical services.

SD SB52

Update certain provisions regarding the Department of Corrections and the authority of the Secretary of Corrections.

SD SB1

Modify debilitating medical conditions for medical cannabis use.

SD HB1053

Prohibit the issuance of a written certification to a pregnant woman or breastfeeding mother for purposes of medical cannabis use.

SD SB3

Prohibit the issuance of a written certification to a pregnant woman or breastfeeding mother for purposes of medical cannabis use.

SD HB1129

Modify and establish provisions related to medical cannabis.

Similar Bills

CA AB602

False advertising: pregnancy-related services.

MI HB5436

Health occupations: pharmacists; pharmacists to prescribe and dispense certain contraceptives; allow. Amends secs. 17703, 17704, 17707, 17708, 17709, 17744, 17751 & 17757 of 1978 PA 368 (MCL 333.17703 et seq.) & adds sec. 17744g.

CA AB50

Pharmacists: furnishing contraceptives.

CA AB968

Contraceptives.

MI SB0219

Health occupations: pharmacists; pharmacists to order and administer certain vaccines and laboratory tests and dispense drugs under certain circumstances; allow. Amends secs. 9204, 9206, 17703, 17707, 17708, 17713, 17751 & 17757 of 1978 PA 368 (MCL 333.9204 et seq.) & adds secs. 17724 & 17724a.

CA SB1379

Pharmacy: remote services.

CA SB569

Controlled substances: prescriptions: declared local, state, or federal emergency.

CA AB1048

Health care: pain management and Schedule II drug prescriptions.